T-DM1 in breast cancer therapeutics: the first drug of its generation

ISSN： 1865-5041

Source： memo - Magazine of European Medical Oncology, Vol.6, Iss.4, 2013-12, pp. : 267-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Breast cancer brain metastases responding to primary systemic therapy with T-DM1

By Bartsch Rupert Berghoff Anna Preusser Matthias

Journal of Neuro-Oncology, Vol. 116, Iss. 1, 2014-01 ,pp. : 205-206

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer

By Junttila Teemu Li Guangmin Parsons Kathryn Phillips Gail Sliwkowski Mark

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 347-356

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1087-1093

Spandidos Publications

Access to resources Recommend Favorite

Induction of differentiation by 1 -hydroxyvitamin D 5 in T47D human breast cancer cells and its interaction with vitamin D receptors

By Lazzaro G. Agadir A. Qing W. Poria M. Mehta R.R. Moriarty R.M. Das Gupta T.K. Zhang X.-K. Mehta R.G.

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 780-786

Elsevier

Access to resources Recommend Favorite

Breast cancer bone metastasis and current small therapeutics

By Cicek Muzaffer

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 635-644

Springer Publishing Company

Access to resources Recommend Favorite